Ambro Injection (Ambroxol Hydrochloride)

Adult administration

As Ambroxol Hydrochloride, administer 15 mg slowly by intravenous injection, 2-3 times a day. In severe cases, it may be increased to 30 mg per dose, and can be given through slow intravenous infusion with normal saline or Ringer's solution. Ages 5 and older: Administer 15 mg once, 2-3 times a day.

Child administration

Administer slowly by intravenous injection at 1.2 to 1.6 mg per kg of body weight per day. Ages 2-4 years: Administer 7.5 mg once, 3 times a day. Under 2 years: Administer 7.5 mg once, 2 times a day. For respiratory distress syndrome.

This medication may cause side effects due to glass fragments when using glass ampoules, so special care must be taken to cut glass ampoules, especially when used for children and the elderly. It should not be used if the patient has an allergy to this medicine or its components. Use with caution in patients with poor kidney function or severely impaired liver function, as well as in children under 2 years of age. Serious side effects, such as severe skin damage, may rarely occur while using this medicine. If abnormalities arise on the skin or mucous membranes, usage should be stopped immediately, and appropriate treatment must be received. Gastrointestinal-related symptoms such as dyspepsia, nausea, vomiting, heartburn, and dry mouth may occasionally occur; rarely, abdominal discomfort, diarrhea, constipation, and loss of appetite may also occur. Skin rashes or allergic reactions, and in severe cases, acute reactions such as anaphylactic shock may occur, so if any unusual symptoms arise, immediate consultation with medical personnel is advised. Caution is necessary when using certain antibiotics with this medicine, as it may increase the secretion of bronchial and pulmonary mucus and elevate the concentration of the antibiotic. The use of this medicine is not recommended, especially during the first three months of pregnancy, and breastfeeding women should carefully consider the necessity and risks as this medicine may be transmitted through breast milk. Elderly patients should use it cautiously as their physical function may decline, potentially requiring a dosage reduction. No specific symptoms have been reported in cases of overdose, but appropriate treatment may be necessary if adverse reactions occur. Headaches, leg pain, and severe fatigue may occur during injection; therefore, it is advisable to inject slowly. This medicine can be administered through slow intravenous infusion mixed with normal saline or Ringer's solution, but should not be mixed with other solutions and should be used within 24 hours of mixing. Finally, this medicine should be stored out of reach of children in a safe location.

Serious side effects

Urticaria, angioedema, respiratory distress, severe acute anaphylaxis reactions (including anaphylactic shock), Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell syndrome).

Mild side effects

Dyspepsia, nausea, vomiting, heartburn, dry mouth, gastrointestinal discomfort, abdominal distension, abdominal pain, diarrhea, constipation, loss of appetite, skin rashes, urticarial-like erythema, itching, facial swelling, fever accompanied by chills, purulent rhinitis with increased white blood cell count, sensory disturbances of the tongue, taste changes, oral numbness, arm numbness, headaches, leg pain, extreme fatigue.

This medicine may be sensitive to light, so it should be stored in a container that prevents light from entering. This will help maintain the effectiveness of the drug for a longer period.

Appearance

A brown ampoule filled with a colorless and transparent liquid.

Package unit

2 mL / ampoule x 50